This session covers key considerations for sites, sponsors and CROs when a sponsor delegates clinical trial agreement negotiation and execution to a CRO.

The speakers address the risks of utilizing CROs for CTA negotiations, additional steps that sites and sponsors should take to ensure they are protected when contracting with CROs and the benefits that CROs can bring to the contract process.

MODERATOR

Sandy Smith - SVP, Clinical Solutions & Strategic Partnering - WCG Clinical

SPEAKERS

Tiffany Yancey - Sr. Program Contracts Manager - United Therapeutics Corporation
Neal Herman - Director, SSU & Regulatory - Syneos Health
David Ebert - Consultant, Board of Directors - Oculus Research